Among 694 participants administered with once-daily IDegAsp in five RCTs [10,25,26,27,28] and 703 participants administered with once-daily basal insulin, 353 (50.9%) and 324 (46.1%) participants had at least one overall confirmed hypoglycemia event, respectively. Here, INS is linked to Hypoglycemia.